Return to homepagePandemic Pact

Utilising novel antimicrobial agents to restore dysregulated immunity to SARS-CoV-2 in high risk patients

  • Funded by British Society for Antimicrobial Chemotherapy (BSAC)
  • Total publications:0 publications

Grant number: BSAC-COVID-09

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $31,250

  • Funder

    British Society for Antimicrobial Chemotherapy (BSAC)

  • Principal Investigator

    Aran Singanayagam

  • Research Location

    United Kingdom

  • Lead Research Institution

    Imperial College London, London, England

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract